It has been reported that the renoprotective factor nuclear factor erythroid 2-related factor 2 (NRF2) can reverse TGFβ1-mediated glomerular fibrosis, but only in the early stages of DN (Jiang et al., 2010). This evidence concerns the gene NFE2L2 and liver dysplastic nodule.